Company intelligence / Profile preview
Mepha
Basel, Basel, Switzerlandmepha.ch ↗
- Ownership
- Private
- Employees
- ~170
- Development stage
- Other
01
Overview
Leading Swiss generic pharmaceutical company with over one-third market share in Switzerland. Offers more than 230 branded and non-branded preparations covering a wide range of therapeutic areas. Known for high-quality standards and innovative drug delivery approaches. Active in malaria research. Now operates as part of Teva Pharmaceutical Industries.[1][2][5][6]
- Therapeutic areas
- CardiovascularImmunologyOtherOncologyInfectious Diseases
- Modalities
- small molecules (branded and non-branded generics)improved branded generics using new formulations or drug delivery technologies[5]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Partnerships to distribute products across Europe, Middle East, Africa, South & Central America [5]; now leverages Teva’s global partnerships
Beyond the preview
Go deeper on Mepha.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mepha.